Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
09/2005
09/22/2005CA2559333A1 Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005CA2555914A1 Therapeutic modulation of ppar (gamma) activity
09/21/2005EP1577307A2 Preparation of thiazoles
09/21/2005EP1575922A1 Biphenyl derivatives and their use as fungicides
09/21/2005EP1575919A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
09/21/2005EP1575900A1 N-methyl amino acids
09/21/2005EP1575575A2 Safe chemical uncouplers for the treatment of obesity
09/21/2005EP1575556A2 Methods to administer epothilone d
09/21/2005EP1303501B1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
09/21/2005CN1671819A Phosphorescent and luminescent conjugated polymers and their use in electroluminescent assemblies
09/21/2005CN1671708A Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
09/21/2005CN1671656A Process for the preparation of thioalkylamine derivatives
09/21/2005CN1671382A Sustained-release tablet composition of pramipexole
09/21/2005CN1671380A Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
09/21/2005CN1219773C Process for preparing 2-chloro-thiazole compound
09/20/2005US6946559 Method of converting functional group through halogen-metal exchange reaction
09/20/2005US6946480 Glutaminyl based DPIV inhibitors
09/20/2005US6946474 Nitrogen-containing compounds and their use as glycine transport inhibitors
09/20/2005US6946467 Serine protease inhibitors
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/20/2005CA2274946C Diphenylalkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them
09/20/2005CA2151604C Application of riluzole in the treatment of neurological lesions associated with traumas
09/15/2005WO2005085241A1 Thiazole derivative
09/15/2005WO2005085219A1 Isothiourea derivatives
09/15/2005WO2005085177A2 Biaryl amino acids and their use in dna binding oligomers
09/15/2005WO2005084222A2 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
09/15/2005WO2005084205A2 Diamino thiazoloindan derivatives and their use
09/15/2005WO2005067502A3 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
09/15/2005WO2005055940A3 Novel m3 muscarinic acetylcholine receptor antagonists
09/15/2005WO2005054430A3 Hepatitis c virus inhibitors
09/15/2005WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
09/15/2005WO2005037258A3 Cyanoguanidine-based azole compounds useful as malonyl-coa decarboxylase inhibitors
09/15/2005WO2004099170A3 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
09/15/2005US20050203151 carboxy- or tetrazole functional thiazole and oxazole compounds; peroxisome proliferator-activated receptor (PPAR) modulators; Type 2 diabetes, syndrome X, dyslipidemia, and atherosclerotic diseases
09/15/2005US20050203149 Alkanamide alpha-monohydrazone derivatives, e.g., N-(4-chlorobenzyl)-2-(4-trifluoromethylphenylhydrazono)propionamide, for agricultural and horticultural use, clothing, food and housing-related use, or livestock and pet use
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
09/15/2005US20050203096 Compounds to treat Alzheimer's disease
09/15/2005US20050203030 Novel effectors of dipeptidyl peptidase IV
09/15/2005CA2556692A1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
09/15/2005CA2556386A1 Isothiourea derivatives
09/14/2005EP1572663A1 Biphenylcarboxamides
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1572630A1 Antibacterial agents
09/14/2005EP1572248A2 Solid-phase fluorination of benzothiazoles
09/14/2005EP1499609A4 Pesticidal heterocycles
09/14/2005EP1409440A4 A method to inhibit ethylene responses in plants
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/13/2005US6943185 Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
09/13/2005US6943170 N-cycloalkylglycines as HIV protease inhibitors
09/13/2005US6943168 Calcium channel inhibitors comprising benzhydril spaced from piperazine
09/09/2005WO2005082871A2 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
09/09/2005WO2005082023A2 Heterocyclic self-immolative linkers and conjugates
09/09/2005WO2005068444A3 Thiazole derivatives and use thereof
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005CA2556752A1 Heterocyclic self-immolative linkers and conjugates
09/08/2005US20050197371 Urea derivatives as PDGFR modulators
09/08/2005US20050197365 Diamino thiazoloindan derivatives and their use
09/08/2005US20050197346 Substituted heterocyclic compounds
09/08/2005US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/08/2005US20050196813 Heterocyclic sulfonamide inhibitors of beta amyloid production
09/07/2005EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1569921A1 Ionic liquids comprising n(cf sb 3 /sb ) sb 2 /sb ] sp - /sp anions
09/07/2005EP1569893A2 Amino substituted hydroxyphenyl benzophenone derivatives
09/07/2005EP1569641A2 Propargyl-trifluoromethoxy-amino-benzothiazole derivatives
09/07/2005EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands
09/07/2005EP1438301B1 Process of production of n-alkyl-2-benzthiazolylsulfeneimides and method of their purification
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005CN1665802A Bisarylsulfonamide compounds and their use in cancer therapy
09/07/2005CN1665795A Method for producing heterocyclic fluoroalkenyl sulfones
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665475A Merocyanine derivatives for cosmetic use
09/07/2005CN1217940C Naphthol derivatives
09/07/2005CN1217933C Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same
09/07/2005CN1217932C Antibacterial agents
09/07/2005CN1217920C Compounds to treat Alzheimer disease
09/07/2005CN1217918C Aminocyclohexyl ether compounds and uses thereof
09/06/2005US6939967 Non-proteinogenic L-amino acids
09/06/2005US6939895 Renalosteodystrophy comprising a compound, or a pharmaceutically acceptable salt or hydrate thereof, having the formula: Ar5-(CHR16)t-W-(CH2)u-CHR17)-NH-CH(R18)-Ar6 wherein: Ar5 is phenyl, indole, carbazole, pyridine,
09/01/2005WO2005081239A1 Optical recording materials having high storage density
09/01/2005WO2005080367A1 Ep2 receptor agonists
09/01/2005WO2005080360A1 Compounds
09/01/2005WO2005080359A1 Benzamide derivatives and their use as glucokinae activating agents
09/01/2005WO2005080334A1 Novel heterocyclic compound
09/01/2005WO2005080322A1 Fluorene derivative
09/01/2005WO2005080317A2 Therapeutic amide derivatives
09/01/2005WO2005079866A1 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof
09/01/2005WO2005079865A1 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
09/01/2005WO2005021523A8 Piperazine substituted compounds used as calcium channel blockers
09/01/2005WO2004054991A8 Ionic liquids comprising [n(cf3)2]- anions
09/01/2005US20050192441 Methods for the preparation of stereoisomerically enriched amines
09/01/2005US20050192440 Method for synthesizing epothilones and epothilone analogs
09/01/2005US20050192430 For use as fluorescent labels with central nervous system drugs
09/01/2005US20050192316 Aryl aniline beta2 adrenergic receptor agonists
09/01/2005US20050192314 Use of urea derivatives of isoxazoles; c-kit kinase inhibitors; anticancer agents; leukemias such as acute myelogenous leukemia (AML), and chronic myelogenous leukemias (CMLs)
09/01/2005US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/01/2005US20050192286 Ligands of melanocortin receptors and compositions and methods related thereto
09/01/2005US20050192231 Treating hepatitis with a cytoprotective agents such as benzyloxycarbonyl-valine-aspartic acid(methyl ester)-methyl fluoride or having leucine and isoleucine as replacements for valine; caspase enzyme inhibitors; fas antigen suppressors; neuroprotective agents; antiischemic agents; organ transplants
09/01/2005US20050192208 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators ; potassium channel moderators; prevent fibrillation
1 ... 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 ... 337